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Abstract
We construct optimal designs for group testing experiments where the goal is to estimate the
prevalence of a trait by using a test with uncertain sensitivity and specificity. Using optimal
design theory for approximate designs, we show that the most efficient design for simultaneously
estimating the prevalence, sensitivity and specificity requires three different group sizes with equal
frequencies. However, if estimating prevalence as accurately as possible is the only focus, the optimal
strategy is to have three group sizes with unequal frequencies. On the basis of a chlamydia study
in the U.S.A., we compare performances of competing designs and provide insights into how the
unknown sensitivity and specificity of the test affect the performance of the prevalence estimator.
We demonstrate that the locally D- and Ds-optimal designs proposed have high efficiencies even
when the prespecified values of the parameters are moderately misspecified.
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1 Introduction
In a group testing study, the goal is often to estimate the prevalence of a rare disease or a particular
trait (Hughes-Oliver & Swallow, 1994; Hughes-Oliver & Rosenberger, 2000). Group testing is frequently
used in studies where testing individuals for a trait is expensive and individual samples are relatively
plentiful. In a group testing study, samples from individuals are pooled and tested as a single unit.
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2Fewer tests or trials are therefore required so that the cost of the study is reduced. (Throughout, we
use the terms trials and tests interchangeably.) The key assumption is that the test result from a group
of individuals is positive if and only if at least one individual in the group has the trait.
Applications of group testing abound in the literature, especially for case diagnosis (McMahan
et al., 2012) and prevalence estimation of diseases (Shipitsyna et al., 2007). Several researchers have
shown that group testing techniques can be used to estimate the prevalence of a rare disease efficiently
(Hughes-Oliver, 2006). Dorfman (1943) gave an early perspective and an overview. From the design
point of view, some key research questions are to determine how many distinct group sizes should be
used, and how many trials at each such group size should be run. In practice, group testing studies
usually have only one group size, but this may be because the potential advantages of using unequal
group sizes have not been well explored.
Much of the work on group testing makes a simplifying assumption that there is no testing error;
see for example, Hughes-Oliver & Rosenberger (2000). In practice, the test in most group testing
experiments is likely to have non-zero error rates, with sensitivity and specificity being less than 100%.
We recall that sensitivity is the probability that the test will be positive given that the sample tested
is truly positive, and specificity is the probability that the test will be negative given that the sample
tested is truly negative.
A few researchers have considered application of group testing when there may be testing errors,
but they assumed that the sensitivity and specificity are known and do not depend on the group size.
When the total number of individuals is fixed and all group sizes are equal, Tu et al. (1995) obtained
the maximum likelihood estimator (MLE) of the prevalence and determined graphically the common
group size that minimizes the variance of the prevalence estimator. For a given group size, Liu et al.
(2012) determined conditions under which group testing performs better than individual testing, when
either the total number of trials or the total number of individuals is fixed.
The sensitivity and specificity can be directly estimated if samples are tested by using both the test
of interest and a “gold standard” test that has no testing errors. Such a gold standard test may not
exist, however, and, even if one does exist, it may be too expensive or complex for routine use. Lacking
a gold standard test, investigators may prespecify sensitivity and specificity values. However, nominal
values may be optimistic, and values that are estimated from different populations could be biased.
Therefore it is more realistic in applications to assume that the sensitivity and specificity of the test are
both unknown. Under this assumption, Zhang et al. (2014) used numerical methods to obtain group
testing designs with or without a gold standard test. Their proposed designs are not fully supported
by theory as being optimal.
When the cost of a test is greater than the cost of collecting an individual sample, it may be
reasonable to design the study by taking the total number of trials, rather than the total number of
individuals, to be fixed. Our goal is to apply optimal design theory to construct optimal group testing
3designs when we have a fixed number of trials, and when both the sensitivity and the specificity of the
test are unknown. We consider two situations: (a) we want to estimate the prevalence, sensitivity and
specificity, all with equal interest; (b) only the prevalence is of interest, but both testing error rates are
treated as nuisance parameters in the design problem.
In the framework of optimal experimental design (Atkinson et al., 2007; Berger & Wong, 2009), the
first setting requires estimating all unknown parameters, and the second setting requires the estimation
of only one of the three unknown parameters in the model. D-optimality as a design criterion is
appropriate for the first situation and Ds-optimality is appropriate for the second situation. The
resulting optimal designs are called D-optimal and Ds-optimal designs respectively. These optimal
designs minimize the generalized variance of all or a subset of the model parameters of interest among
all designs, so they provide the most accurate inference for all three or just the prevalence parameter.
Other design criteria, such as A-optimality or c-optimality, can also be used.
Our set-up is different from earlier studies for finding efficient or optimal designs for group testing
experiments, such as Tu et al. (1995) and Zhang et al. (2014). The main differences are that (a) our
optimal designs are sought among all possible designs without any restriction on the number of different
group sizes, and (b) our optimal designs are justified by theory. Tu?s results are more restrictive because
their designs are sought among all designs with a common group size and cannot incorporate uncertainty
in testing error rates. Zhang?s designs are obtained by numerical optimization with dimension as large
as the upper bound of the group sizes; therefore their global optimality cannot be guaranteed, and we
may not be able to interpret how prespecified parameter values affect their optimal designs. To our best
knowledge, our work is the first that uses optimal design theory to provide a theoretical justification
for designing group testing experiments when testing error rates are uncertain.
The organization of our paper is as follows. Section 2 describes the statistical background. Section
3 constructs optimal group testing designs for the two situations that were described above. In Section
4, we evaluate the finite sample properties and robustness properties of our proposed optimal designs
when the parameter vector is misspecified. The set-up of the simulation is based on a chlamydia study
conducted in the U.S.A. We end the paper with a discussion in Section 5 with remarks on alternative
methods and ideas for further research directions in this area.
All computations in this paper were done by using our code called gtest.nb developed by using
Mathematica 10.0; see Wolfram (2015) for more details. The package can be freely downloaded from
http://www.math.nsysu.edu.tw/~lomn/huangsh/.
2 Preliminaries
Throughout, we denote the prevalence, sensitivity and specificity of the test by p0, p1 and p2, respec-
tively. We assume that p0 ∈ (0, 1), p1, p2 ∈ (0.5, 1], and the two types of testing errors occur randomly
4with testing error rates 1 − p1 and 1 − p2 respectively. Letting θ = (p0, p1, p2)T, a direct calculation
shows that the probability of a positive response (either a true positive or a false positive) for a trial
with group size x is
pi(x) = pi(x|θ) = p1 (1− (1− p0)x) + (1− p2) (1− p0)x = p1 − (p1 + p2 − 1) (1− p0)x . (1)
In practice, there are generally limits on the group sizes so we consider designs that are subject to a
known group size constraint 1 ≤ xL ≤ x ≤ xU <∞. We note that pi(x) is a convex combination of p1
and 1−p2. For a study consisting of n trials at k distinct group sizes x1 < x2 · · · < xk, the log-likelihood
function of θ is
L(θ) =
k∑
i=1
{yi log(pi(xi|θ)) + (ni − yi) log(1− pi(xi|θ))}, (2)
apart from an unimportant additive constant. Here each yi is the number of positive responses among
the ni trials at group size xi and
∑k
i=1 ni = n. We assume that each yi has a binomial distribution
with parameters (ni, pi(xi|θ)), and the {yi}ki=1 are mutually independent.
In what follows, we work with approximate designs advocated by Kiefer (1974). An approximate
group testing design denoted by ξ = {(xi, wi)}ki=1 contains k distinct group sizes (or support points)
x1 < x2 < · · · < xk and corresponding weights w1, w2, . . . , wk, where
∑k
i=1 wi = 1 and each wi > 0
is interpreted as the proportion of trials at group size xi. When the total number of trials n is fixed
a priori by either cost or practical considerations, the group testing design ξ takes nwi groups of size
xi, i = 1, . . . , k subject to nw1 + . . .+ nwk = n. In reality, the group sizes and the numbers of trials at
these sizes must be positive integers. Therefore, optimal approximate group testing designs are rounded
before implementation so that each group size and its frequency are positive integers. We call such
designs rounded optimal designs. Simple rounding procedures to obtain a design for implementation
have been shown to produce little loss in efficiency. More efficient rounding apportionment introduced
in section 12.5 of Pukelsheim (2006) can also be applied to obtain the optimal number of trials at the
rounded group size.
Under model (1), the maximum likelihood estimator (MLE) of θ is obtained by maximizing (2). If
design ξ were used to obtain the data, a direct calculation shows the covariance matrix of the estimated
θ is asymptotically proportional to the inverse of the 3× 3 Fisher information matrix given by
M(ξ) =
k∑
i=1
wiλ(xi)f(xi)f(xi)
T = Mf (ξ) ·Diagλ(ξ) ·Mf (ξ)T. (3)
5Here
λ(x) = [pi(x)(1− pi(x))]−1,
f(x) = (f0(x), f1(x), f2(x))
T,
f0(x) = ∂pi(x)/∂p0 = x(p1 + p2 − 1)(1− p0)x−1,
f1(x) = ∂pi(x)/∂p1 = 1− (1− p0)x,
f2(x) = ∂pi(x)/∂p2 = −(1− p0)x,
Mf (ξ) = (f(x1), f(x2), · · · , f(xk)) ∈ R3×k, (4)
and Diagλ(ξ) is a k × k diagonal matrix with elements {wiλ(xi)}ki=1.
The design we seek for estimating θ is a D-optimal design that maximizes the determinant of the
information matrix (3), or equivalently a design that minimizes the generalized variance of all parameter
estimators, by choice of k, x1, . . . , xk, w1, . . . , wk. In other words, a D-optimal design maximizes
ΦD[M(ξ)] = log |M(ξ)| (5)
among all possible designs under which θ is estimable. When we are interested in estimating only a
subset of the model parameters, we use the Ds-optimality criterion. Here we are interested in accurately
estimating only the prevalence, and we treat sensitivity and specificity as nuisance parameters. The
Ds-criterion here is to minimize only the asymptotic variance of the prevalence estimator. Such a
Ds-optimal design maximizes
Φs[M(ξ)] = − log
(
M(ξ)−
)
11
(6)
among all designs under which p0 is estimable, where M− is a generalized inverse of matrix M and we
use the notation O11 to denote the (1, 1) entry of the matrix O. Note that the Ds-optimality above is
equivalent to c-optimality with c = (1, 0, 0)T (Fedorov, 1972).
The solutions to our optimization problems require solving the equations in Lemma 1 below. Its
proof mainly requires calculus and the intermediate value theorem and has therefore been omitted.
Before stating Lemma 1, we introduce further notation. Let
c = p1/{(p1 + p2 − 1)(1− p0)xL} > 1,
δ = (1− p1)/p1 ∈ [0, 1),
r = (1− p0)xU−xL ∈ (0, 1), and
∆0 = r log(r)/(1− r).
6For a ∈ (r, 1), let
∆1(a) =
(a− r)√(c− 1)(δc+ 1) + (1− a)√(c− r)(δc+ r)
(1− r)√(c− a)(δc+ a) ,
and let
∆2(a) =
√
(c− 1)(δc+ 1)−√(c− r)(δc+ r)
(1− r)√(c− a)(δc+ a) .
These definitions imply that r < a < 1 < c which is used in the proofs without further mention.
Lemma 1 Each of the following equations has a root a ∈ (r, 1):
2
a
(
1 +
1 + ∆0 × 1a
log(a)−∆0 ×
(
1
a − 1
)) = 1
δc+ a
− 1
c− a, (7)
and
2 (1 + ∆1(a))
a
(
1 +
1 + ∆0 × 1a
log(a)−∆0 ×
(
1
a − 1
)) = 1
δc+ a
− 1
c− a + 2∆2(a). (8)
3 The D- and Ds-optimal designs
Before characterizing the D- and Ds-optimal designs, we first characterize a small class of designs
guaranteed to contain D- and Ds-optimal designs, and then we obtain the optimal designs from the
class. Such an approach is based on the so-called “essentially complete classes” used in Cheng (1995)
and Yang & Stufken (2009), among others, to identify optimal designs in certain settings. Recently,
a series of references, including Yang & Stufken (2012) and Hu et al. (2015), proposed a framework
to obtain essentially complete classes, and provided several important properties of optimal designs
identified in the class. We follow such an approach.
A class C is called an essentially complete class if, for an arbitrary design ξ1 /∈ C, there exists a design
ξ2 ∈ C such that M(ξ2) −M(ξ1) is nonnegative definite. Therefore, it guarantees that there exists an
optimal design in C when the design criterion has certain properties such as concavity, isotonicity, and
smoothness. For example, Assumption A in Hu et al. (2015) includes criteria like D- and Ds-optimality,
and other criteria based on the information matrix. Let
C0 =
{
{(xi, wi)}3i=1 : xL = x1 < x2 < x3 ≤ xU ,
3∑
i=1
wi = 1, wi ≥ 0
}
.
By allowing wi = 0 at some points, this class contains all one- and two-point designs, and all three-point
7designs with a support point at xL. By applying Theorem 2(a) in Yang & Stufken (2012), we have the
following theorem which allows us to search for a D- and a Ds-optimal group testing design in C0.
Theorem 1 The class C0 is essentially complete.
The justifications of this result and others are given in the Appendix.
3.1 The unique D-optimal design
When we wish to estimate prevalence, sensitivity, and specificity simultaneously, we need a design with
at least three points to estimate the three parameters. The sought design is a D-optimal design for
estimating the three parameters of the model. From Theorem 1, such a D-optimal group testing design
exists in C0 and the following theorem ensures the uniqueness of the D-optimal design and characterizes
it.
Theorem 2 The D-optimal design ξD for estimating the prevalence and the two testing error rates is
unique. It has three group sizes xL, x∗2, and xU with equal weights, where x∗2 − xL = log(A1)/ log(1− p0)
and A1 uniquely solves (7).
Theorem 2 asserts that the D-optimal design requires equal numbers of trials at three distinct group
sizes, with two of them being the extreme sizes xL and xU . No design with four or more group sizes can
estimate the three parameters more accurately than the D-optimal design. In addition, our proof of
Theorem 2 implies that (a) the root of equation (7) must be unique in (r, 1), or otherwise it contradicts
the uniqueness of the D-optimal design, and (b) either having a smaller value of xL or having a larger
value of xU always strictly reduces the generalized variance of the MLE of θ. Thus, we suggest the
lower bound xL to be one whenever possible. However, too large a value of xU may cause a dilution
effect (Zenios & Wein, 1998), impacting the sensitivity or the specificity of the test. Thus, the upper
bound xU should be set carefully.
When p0 and xL are small and xU is large, we observe that pi(xL) is close to 1 − p2 and pi(xU )
is close to p1, which implies that trials at size xL and xU mainly provide information for p2 and p1
respectively. We may conclude that x∗2 contributes most for estimating p0. In practice, p1 and p2 for a
given test may be estimated by comparing the test results with a gold standard test having no testing
errors. In the absence of a gold standard, the maximum likelihood approach can be seen as comparing
the test results from the intermediate group size with those from the two extreme group sizes, to acquire
information about the error parameters p1, p2, and the prevalence p0. Accordingly, we may regard the
test results from the two extreme group sizes as playing a similar role to that of a gold standard test
for providing information on p1 and p2.
83.2 The unique Ds-optimal design
Theorem 2 assumes that there is equal interest in estimating prevalence, sensitivity and specificity. In
practice, the interest is usually to accurately estimate the prevalence alone, and the sensitivity and
specificity of the test are treated as unknown nuisance parameters. When the main goal is only to
estimate the prevalence as accurately as possible, the Ds-optimality criterion (6) is the most suitable.
A Ds-optimal design minimizes the (1, 1) element of the inverse of the information matrix (3), which is
proportional to the asymptotic variance of the prevalence estimator.
To determine the optimal weights under the Ds-criterion for a fixed number of group sizes, suppose
that there are three group sizes x1 < x2 < x3 in the allowable range [xL, xU ]. Let
Qi(x1, x2, x3) = λ(xi)
−1
{
(1− p0)x
(i)
1 − (1− p0)x
(i)
2
}2
> 0,
for i = 1, 2, 3, where x(i)1 and x
(i)
2 are the two group sizes of {x1, x2, x3} \ {xi} such that x(i)1 < x(i)2 .
To be more specific, x(1)1 = x2, x
(1)
2 = x3, x
(2)
1 = x1, x
(2)
2 = x3, x
(3)
1 = x1, and x
(3)
2 = x2. For any
group testing design with three group sizes, the next lemma prescribes the optimal weights under the
Ds-criterion.
Lemma 2 For any group testing design with three group sizes, x1, x2, and x3 ∈ [xL, xU ], the optimal
weights under the Ds-criterion for only estimating the prevalence are unique and given by
wsi =
Qi(x1, x2, x3)
1/2∑3
j=1Qj(x1, x2, x3)
1/2
(9)
for i = 1, 2, and 3, and
max Φs[M(ξ)] = log |Mf (ξ)|2 − 2 log
(
3∑
i=1
Qi(x1, x2, x3)
1/2
)
. (10)
Our next result gives a complete description of the Ds-optimal design for estimating the prevalence
when the testing error rates are unknown.
Theorem 3 The Ds-optimal design ξs for estimating the prevalence alone is unique and requires three
group sizes xL, xs2, and xU , where xs2 − xL = log(As)/ log(1 − p0) and As uniquely solves (8). The
proportions of groups with such sizes are given in (9) in Lemma 2.
We observe that (8) approximates (7) when ∆1 and ∆2 are both close to zero, which may occur in
practice when pi(xL) tends to zero and pi(xU ) tends to one. Consequently, A1 ≈ As, and the intermediate
support point xs2 of the Ds-optimal design for estimating the prevalence is close to the intermediate
support x∗2 of the corresponding D-optimal design.
9Theorem 3 shows that the Ds-optimal design for estimating prevalence with unknown testing error
rates has similar properties to those of the D-optimal design for estimating the three parameters. In
particular, (a) no design with four or more different group sizes can estimate the prevalence more
accurately than the Ds-optimal design with three different group sizes, (b) the root of equation (8)
must be unique in (r, 1), (c) either having a smaller value of xL or having a larger value of xU strictly
improves the accuracy of prevalence estimation, and (d) groups with size xL and xU mainly contribute
information about the specificity and sensitivity, respectively, and the groups with the intermediate size
mainly contribute information about the prevalence.
When xL is small and xU is large, which implies that pi(xL) is much smaller than 0.5 and pi(xU ) is
much larger than 0.5 by (1), then Q2(xL, xs2, xU ) is much larger than Q1(xL, xs2, xU ) and Q3(xL, xs2, xU ).
Consequently, the proportion of groups with the intermediate size is much larger than the other two
group sizes. This observation is not surprising partly because the Ds-optimal design criterion seeks
information for the prevalence only and does so by having more groups with the intermediate size.
4 Design performance
The optimal designs discussed in the previous section are locally optimal approximate designs, and
their group sizes and the number of trials at each group size must be rounded to positive integers for
implementation. In addition, their information matrices are based on the asymptotic distribution of the
MLE of the parameter vector. In what follows, we study the properties of the rounded optimal designs
when we have moderate sample size (total number of trials), and their sensitive to the prespecified value
of the parameter vector.
Recall that θ = (p0, p1, p2)T is the true but unknown vector of parameters in our model, [xL, xU ] is
the user-specified allowable range of group sizes, and we are interested in either estimating θ or only the
prevalence parameter p0. For an approximate design ξ = {(xi, wi)}ki=1 with integer-valued group sizes,
denote its exact design with n trials as ξ(n) = {(xi, ni/n)}ki=1, where n1, . . . , nk are integers obtained
by applying the efficient rounding apportionment (Pukelsheim, 2006, section 12.5) to {nw1, . . . , nwk}.
Let θˆξ(n) be the MLE of the parameter vector θ under the exact design ξ(n). We define the mean
squared error matrix of θˆξ(n) (scaled by sample size n) by
mse(θˆξ(n)) = nE
[
(θˆξ(n) − θ)(θˆξ(n) − θ)T
]
. (11)
Note that mse(θˆξ(n)) converges to M(ξ)−1 as n goes to infinity by the asymptotic property of MLE.
The analytical form of mse(θˆξ(n)) is quite complicated unless the sample size n is very small. We
therefore study mse(θˆξ(n)) by simulation as follows. Let N be the number of simulation replications.
For t = 1, . . . , N , we simulate a sample of n trials generated from ξ(n), consisting of ni binary outcomes
10
with response probability pi(xi|θ) for i = 1 . . . k, and compute θˆ(t)ξ(n), the MLE of θ from the sample.
The simulation-based mean squared error matrix of ξ is defined by
m̂se(θˆξ(n)) =
n
N
N∑
t=1
(θˆ
(t)
ξ(n) − θ)(θˆ(t)ξ(n) − θ)T. (12)
We use two measures to assess the finite sample performance of ξ(n). They are the (simulation-based)
D- and Ds-efficiencies, defined respectively, by
effD{ξ(n)} =
{
|M(ξD)−1|
|m̂se(θˆξ(n))|
}1/3
and effs{ξ(n)} = M(ξs)
−1
11
m̂se(θˆξ(n))11
, (13)
where ξD and ξs are the D- and Ds-optimal designs obtained from Theorems 2 and 3.
In the following, we set the number of simulation replications to N = 10000, and set the prespecified
values of the test parameters to match the Chlamydia study from Nebraska, the U.S.A. (McMahan et al.,
2012, Table 1). McMahan et al. (2012) prespecified the prevalence to be 0.07, and the sensitivity and
specificity to be 0.93 and 0.96 for female’s swab specimens. Suppose we have a budget for n = 3000
trials, and the allowable range of the group size is [xL, xU ] = [1, 61].
4.1 Finite sample performance of the rounded optimal designs
First, we construct the D- and Ds-optimal designs, and show that the effects of rounding (both the
group sizes and their number of support points) and the use of asymptotic approximations are small.
Under θ = (0.07, 0.93, 0.96)T and [xL, xU ] = [1, 61], the D-optimal design ξD from Theorem 2 is equally
supported on {1, 16.79, 61}. For n = 3000, its rounded design ξ′D(3000) has group sizes {1, 17, 61} with
1000 groups per size.
Similarly, the Ds-optimal design ξs obtained from Theorem 3 is supported on {1, 15.68, 61}. Its
rounded design ξ′s(3000) is therefore supported on {1, 16, 61}, and has {393, 1884, 723} trials at {1, 16, 61}
respectively. These numbers of trials are based on the Ds-optimal weights on {1, 16, 61} by Lemma
2, which are slightly different from the weights of ξs. The simulation results in Table 1 show that the
D-efficiency of ξ′D(3000) and the Ds-efficiency of ξ
′
s(3000) are both close to one. This indicates that
the performance of the rounded D- (and Ds-) optimal design is similar to the asymptotic performance
of the D- (and Ds-) optimal approximate design.
Next, we compare the finite sample performance of the rounded D- and Ds-optimal designs to k-
point uniform designs ξ(k)U (n), supported on the positive integers {1 + 60ik−1 : i = 0, . . . , k − 1}, for
k = 3, . . . , 6. For example, ξ(4)U (3000) has 750 trials at each group size of {1, 21, 41, 61}. Table 1
also shows the performance of these k-point uniform designs. We observe that, although the optimal
designs ξD and ξs have exactly three support points, ξ
(3)
U (3000) is not the best among these uniform
11
Table 1: The D- and Ds-efficiencies of the rounded D- and Ds-optimal designs, and the k-point uniform
designs for k = 3, . . . , 6.
Design ξ′D(3000) ξ
′
s(3000) ξ
(3)
U (3000) ξ
(4)
U (3000) ξ
(5)
U (3000) ξ
(6)
U (3000)
effD 0.9904 0.8193 0.7988 0.8456 0.8133 0.7805
effs 0.6977 1.0052 0.3170 0.4851 0.5274 0.5509
designs regarding D- or Ds-efficiency. In contrast, ξ
(4)
U (3000) performs best for estimating θ among
these uniform designs, but its D-efficiency is about 0.85 and is less than effD(ξ′D(3000)). Furthermore,
the design ξ(6)U (3000) has highest Ds-efficiency among these uniform designs, but its Ds-efficiency is
only about 0.55 and is significantly less than effs(ξ′s(3000)). This indicates that, when focusing on
estimating θ (or p0), the rounded D- (or Ds-) optimal design under the true parameter vector performs
much better than the uniform designs above.
4.2 Robustness of the rounded optimal designs
Now we consider the situation where the prespecified value of θ used in the local design construc-
tion is incorrect. Specifically, suppose that the prespecified parameter vector θ˜ = (p˜0, p˜1, p˜2)T is
a point in the region Θ = [0.01, 0.10] × [0.9, 1]2, containing the true value of the parameter vector
θ = (0.07, 0.93, 0.96)T.
Let ξ′
D,θ˜
(3000) be the rounded D-optimal design under the prespecified parameter vector θ˜. In
D-optimality, the prespecified value of the parameter vector only affects the intermediate group size
x∗2 in Theorem 2, but does not affect the other two group sizes and the weights on the three support
points. Hence, ξ′
D,θ˜
(3000) is equally supported on {1, x˜, 61}, where x˜ depends on θ˜. Figure 1 shows
the corresponding x˜ for selected θ˜ ∈ Θ. We observe that when the specified θ˜ is within Θ, x˜ shifts
from 12 to 25, where x˜ = 17 for θ˜ = θ; x˜ increases as p˜0 or p˜2 decreases, or as p˜1 increases. When the
prevalence is small such as 0.01, the specificity seems to play a dominant role on the D-optimal design,
whereas, as the prevalence gets larger, the dominant factor shifts from the specificity to sensitivity; and
the sensitivity and specificity have similar effect on the design when the prevalence is close to 0.04.
Figure 2 shows the D-efficiency of ξ′
D,θ˜
(3000) for θ˜ ∈ Θ in terms of x˜, where x˜ = 12 to 25. Generally,
these rounded D-optimal designs under misspecified θ˜ ∈ Θ have D-efficiencies greater than 90%. Note
that the rounded D-optimal design is equally supported on three group sizes including two extreme
ones. In contrast, the design ξ(3)U has the same form but its D-efficiency is only about 0.8. This indicates
that the rounded D-optimal design under a misspecified parameter vector is quite robust for estimating
θ.
Similar to the parameter misspecification setting for the D-optimal design, we obtain the rounded
Ds-optimal designs designs ξ′s,θ˜(3000) supported on {1, x˜s, 61} under a possibly misspecified parameter
vector θ˜, where x˜s depends on θ˜ ∈ Θ. A direct calculation shows that the intermediate group size x˜s
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Figure 1: The intermediate group size x˜ of the rounded D-optimal designs under a prespecified
θ˜ = (p˜0, p˜1, p˜2)
T. Here p˜0 = 0.01, 0.04, 0.07, and 0.10; p˜1 and p˜2 = 0.90, 0.91, . . . , 0.99, and 1.00.
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Figure 2: The D-efficiency of the design that is equally supported on {1, x˜, 61} with n = 3000, for
x˜ = 12 to 25. These designs arise as rounded D-optimal designs for θ˜ ∈ Θ as defined in the text.
is between 11 and 25, and the weights of group sizes 1, x˜s, and 61 are respectively within 0.14± 0.05,
0.67± 0.14, and 0.19± 0.12.
Figure 3 shows the Ds-efficiencies of ξ′s,θ˜(3000) for selected θ˜ ∈ Θ. We observe that eff{ξ′s,θ˜(3000)}
is larger than or close to 0.8 when the prespecified θ˜ belongs in the region [0.04, 0.10] × [0.90, 0.99] ×
[0.90, 1.00] ⊂ Θ, which limits the distance from θ˜ to the true value of θ = (0.07, 0.93, 0.96)T. However,
when p˜0 = 0.01 (not near the true prevalence p0 = 0.07) or p˜1 = 1.00 (not near the true sensitivity
p1 = 0.93), eff{ξ′s,θ˜(3000)} drops to as low as 0.6. We observe that the Ds-optimal design is slightly
more sensitive than the D-optimal design when there is substantial parameter misspecification, but still
performs well when the prespecified parameter vector is not far from its true value.
Finally, comparing Figures 2 and 3 to Table 1, we observe that when the prespecified values of
parameters are moderately misspecified, a rounded D- (or Ds-) optimal design still has at least 0.9
D-efficiency (or 0.8 Ds-efficiency), but those uniform designs only have at most 0.85 D-efficiency (or
0.55 Ds-efficiency). Our conclusion is that when we wish to estimate θ (or p0), we would recommend
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Figure 3: The Ds-efficiency of the rounded Ds-optimal design ξ′s,θ˜(3000) under prespecified θ˜ =
(p˜0, p˜1, p˜2)
T. Here p˜0 = 0.01, 0.04, 0.07, and 0.10; p˜1 = 0.90 (dashed), 0.93 (thick), 0.96 (dotted),
0.99 (dot-dashed), and 1.00 (thin); p˜2 = 0.90, 0.93, 0.96, 0.99, and 1.00.
implementing a rounded D- (or Ds-) optimal design over any of the uniform design that we had
investigated.
5 Discussion
Our work addresses several design issues for group testing studies using optimal design theory. Under
uncertain testing error rates, we provide locally optimal designs for estimating prevalence alone or
jointly with sensitivity and specificity. Our designs are justified by rigorous theoretical analysis and
they provide the most accurate parameter estimates among all group testing designs. By contrasting the
D- and Ds-optimal designs, we observe that relatively fewer trials at extreme group sizes are required
in the Ds-optimal design, where the sensitivity and specificity are treated as nuisance parameters in
the Ds-criterion. In the optimal approximate design, the theoretical group sizes and the frequencies of
the group sizes are not guaranteed to be integers. We show by simulations that the rounded D- and
Ds-optimal designs still have very high efficiencies. In addition, our simulation results show that our
designs are still quite robust when the prespecified values of parameters are not far from their true
values.
Although our theoretical results apply in general, our simulation studies focused on settings with
3000 trials, and had a maximum group size of approximately 60. This can be compared to two published
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studies using group testing: one in Russia estimating Chlamydia prevalence (Shipitsyna et al., 2007),
which had three designs, involving 150 to 1500 trials, and one in the U.S.A. focusing on Chlamydia
diagnosis (McMahan et al., 2012), which used 7000 trials. Thus the number of trials in our simulation
study is similar to what has been used in practice, where the estimation burden is lighter because the
sensitivity and specificity are treated as known there. We also note that the number of individual
samples in our simulation example is larger than what were used in these two real-world studies.
Since our designs are optimal, this reflects the unavoidable cost of estimating the prevalence as well as
sensitivity and specificity from a single dataset with no prior knowledge about any of the parameters.
Our locally optimal designs can be used in the multi-stage adaptive approach as in Hughes-Oliver
& Swallow (1994), where they assumed no testing errors. For example, a D- or Ds-optimal design may
be implemented based on any available prior knowledge from the first stage. In the subsequent stages,
we construct a D- or Ds-optimal design based on the information about the parameters obtained in
the previous stages. Alternatively, a Bayesian optimal design approach or a minimax approach (Dette
et al., 2014) can be implemented. For example, the experimenters may obtain a design that maximizes
Ds-optimality criterion averaged over the parameters with respect to their prior distribution, or a design
that minimizes the largest possible variance of the prevalence estimator among different values for the
parameters. Such Bayesian or minimax optimization problems are difficult to address theoretically and
even numerically, but are of interest for future studies.
The results presented here are appropriate for a setting in which the testing errors occur randomly
and are unrelated to the group size within a prespecified range. In practice, the plausible range of
group sizes comes from cost considerations or the physical constraints imposed on the study. A careful
decision about the range of values for the group sizes is important because a group size that is too
large may cause dilution effects, which in turn, may reduce the sensitivity and the specificity of the
test. Our group testing framework can potentially be extended to accommodate dilution effects and
other complicating issues, such as stratified populations. For example, we may wish to estimate the
prevalence of a rare trait in multiple geographic regions with potentially different disease prevalences,
or when the sensitivity and specificity of the test vary among the sub-populations. Such issues may be
interesting directions for future research.
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Appendix
Before giving the proofs of Theorem 1, Theorem 2, Lemma 2, and Theorem 3, we introduce additional
notation. Let
ai = (1− p0)xi−xL ∈ [r, 1], for i = 1, 2, . . . , k,
C(a) =
1
(c− a)(δc+ a)
 a log(a)c− a
δc+ a

 a log(a)c− a
δc+ a

T
=

(a log(a))2
(c−a)(δc+a)
a log(a)
c−a
a log(a)
δc+a
a log(a)
c−a
c−a
δc+a
1
a log(a)
δc+a
1 δc+a
c−a

=
 Ψ5(a) Ψ4(a) Ψ3(a)Ψ4(a) Ψ1(a) Ψ0
Ψ3(a) Ψ0 Ψ2(a)
,
P1 =

(p1+p2−1)(1−p0)xL−1
log(1−p0) (p1 + p2 − 1)xL(1− p0)
xL−1 0
0 −(1− p0)xL 1
0 −(1− p0)xL 0
, and
P2 =
 1 0 00 −1 c
0 1 δc

−1
.
Proof of Theorem 1
We use Theorem 2(a) in Yang & Stufken (2012) to show that C0 is essentially complete. First we rewrite
the information matrix (3) as
M(ξ) =
1
(p1 + p2 − 1)2(1− p0)2xL (P1·P2)
(
k∑
i=1
wiC(ai)
)
(P1·P2)T. (14)
Let fi,1(a) = dΨi(a)/da for i = 1, . . . , 5 and let
fi,j(a) =
d
da
(
fi,j−1(a)
fj−1,j−1(a)
)
, for j = 2, . . . , 5 and i = j, . . . , 5.
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Then for a ∈ [r, 1] ⊂ (0, 1], we have
f1,1(a) = − c+ δc
(δc+ a)2
< 0; f2,2(a) = −2(c+ δc)(δc+ a)
(c− a)3 < 0; f3,3(a) = −
(c− a)2(2a+ c)
2a2(c+ δc)2
< 0;
f4,4(a) = − 2(c+ δc)
(2a+ c)2
< 0; f5,5(a) =
4a+ 2c
a(c+ δc)
> 0.
Therefore,
∏5
i=1 fi,i(a) =
4
a3(c−a)(δc+a) > 0 for a ∈ [r, 1]. Hence, the group testing model satisfies the
conditions for Theorem 2(a) in Yang & Stufken (2012), and therefore the designs having at most two
points together with the designs having three points including xL (which coincides with a = 1) form an
essentially complete class. In addition, according to the proof of Theorem 2 in Yang & Stufken (2012),
it can be shown that there exists s0, . . . , s5 = ±1 such that
{siΨi}5i=0 is a Chebyshev system on [r, 1]. (15)
This property will be used in the proof of Theorem 3.
Proof of Theorem 2
There are 3 steps in the proof. In step (a) we show that the D-optimal design is unique and requires
three group sizes with equal frequencies, including one being the smallest group size xL. In step (b), we
show that the upper bound xU is a support point of the D-optimal design. In step (c), we determine
the intermediate group size.
(a) By Theorem 1 and the fact that θ is only estimable under a design with at least 3 group sizes,
there exists a D-optimal design ξD belonging to C0 with exactly 3 group sizes and one of them is
xL. Because the number of support points of the D-optimal design ξD is equal to the number of
unknown parameters, ξD must be equally supported (see for example, section 8.12 of Pukelsheim
(2006)). By Theorem 2.5 in Hu et al. (2015) and the fact that D- and Φ0-criteria are equivalent,
it follows that ξD is the unique D-optimal design.
(b) Following (a), we denote the uniqueD-optimal design as ξD = {(x∗i , 13 )}3i=1, where xL = x∗1 < x∗2 <
x∗3 ≤ xU . Recall that ai = (1− p0)x
∗
i−xL (x∗1 = xL implies that a1 = 1) and r = (1− p0)xU−xL . It
suffices to show that ∂ΦD[M(ξD)]∂a3 < 0 for all a3 ∈ [r, a2), i.e., the D-criterion is a strictly decreasing
function of a3. Thus the criterion is maximized by taking a3 as small as possible, which implies
x∗3 = xU .
By (14), the information matrix of ξD can be written as
M(ξD) =
1
(p1 + p2 − 1)2(1− p0)2xL P1
(
3∑
i=1
1
3
P2C(ai)P
T
2
)
PT1 ,
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where
3∑
i=1
1
3
P2C(ai)P
T
2 =
3∑
i=1
1
3(c− ai)(δc+ ai)
 ai log(ai)ai
1

 ai log(ai)ai
1

T
= Γ1Γ2Γ
T
1 ;
Γ1 =
 0 a2 log(a2) a3 log(a3)1 a2 a3
1 1 1
;
Γ2 =

1
3(c−1)(δc+1) 0 0
0 1
3(c−a2)(δc+a2) 0
0 0 1
3(c−a3)(δc+a3)
.
A direct calculation shows
∂ΦD[M(ξD)]
∂a3
=
∂
∂a3
log
(
|Γ1|2 |Γ2|
)
=
2
|Γ1| ×
∂ |Γ1|
∂a3
+
1
c− a3 −
1
δc+ a3
,
and the following statements are true by calculus:
(i) 1c−a3 − 1δc+a3 < 1c−a3 − 1c+a3 = 2a3c2−a23 <
2a3
1−a23 ;
(ii) ∂|Γ1|∂a3 = 1− a2 + a2 log(a2) + (1− a2) log(a3) < 1− a2 + a2 log(a2) + (1− a2) log(a2)
= 1− a2 + log(a2) < 0 for all 0 < a3 < a2 < 1;
(iii) |Γ1| = a3(1− a2) log(a3)− a2(1− a3) log(a2) > lim
a3→a2
|Γ1| = 0;
(iv) (1−a23)∂|Γ1|∂a3 +a3|Γ1| = (1−a3)(a2 log(a2) +a3(1−a2))− (1−a2)(− log(a3) + (1−a3)a3)<0.
The last assertion holds because a2 log(a2) + a3(1 − a2)) < a2 log(a2) + a2(1 − a2)) < 0 and
(− log(a3) + (1− a3)a3) > 0 for all 0 < a3 < a2 < 1. Consequently,
∂ΦD[M(ξD)]
∂a3
<
2
|Γ1| ×
∂ |Γ1|
∂a3
+
2a3
1− a23
=
2
|Γ1| (1− a23)
(
(1− a23)
∂ |Γ1|
∂a3
+ a3 |Γ1|
)
< 0
and the desired result holds.
(c) Our remaining goal is to determine x∗2. We do this by showing that ∂ΦD[M(ξD)]/∂a2 = 0 is
equivalent to (7), and hence x∗2 = xL +
logA1
log(1−p0) , where A1 is the solution of (7). In (b) we have
shown that the optimal choice for a3 is a∗3 = (1 − p0)xU−xL = r. By arguments similar to step
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(b), we have that
0 =
∂ΦD[M(ξD)]
∂a2
=
2
|Γ1| ×
∂ |Γ1|
∂a2
+
1
c− a2 −
1
δc+ a2
=
2{(1− r)(1 + log(a2)) + r log(r)}
(1− r)a2 log(a2) + a2r log(r)− r log(r) +
1
c− a2 −
1
δc+ a2
=
2
a2
(
1 +
1 + ∆0 × 1a2
log(a2)−∆0
(
1
a − 1
))+ 1
c− a2 −
1
δc+ a2
which is equivalent to (7), and hence the proof is complete.
Proof of Lemma 2
Let ξ be a design supported on {x1, x2, x3} with x1 < x2 < x3. Our problem here is to find the
vector of the positive weights {wsi }3i=1 at these three given points that minimizes (M(ξ)−)11, where
M(ξ) = Mf (ξ) · Diagλ(ξ) · Mf (ξ)T, Mf (ξ) = (f(x1) f(x2) f(x3)) is nonsingular and Diagλ(ξ) =
diag(ws1λ(x1), . . . , w
s
3λ(x3)) is positive-definite. Let e1 = (1, 0, 0)T. Then
Mf (ξ)
−1 · e1 = 1|Mf (ξ)|

(1− p0)x2 − (1− p0)x3
(1− p0)x3 − (1− p0)x1
(1− p0)x1 − (1− p0)x2

and we have
(
M(ξ)−
)
11
= eT1 · (Mf (ξ)−1)T ·Diagλ(ξ)−1 ·Mf (ξ)−1 · e1
=
(
Mf (ξ)
−1 · e1
)T ·Diagλ(ξ)−1 · (Mf (ξ)−1 · e1)
=
1
|Mf (ξ)|2
3∑
i=1
Qi(x1, x2, x3)
wsi
. (16)
Since Qi(x1, x2, x3) > 0 for i = 1, 2, 3 and |Mf (ξ)|2 > 0, we apply the method of Lagrange multipliers
directly to minimize the value in (16) subject to the constraints on the weights. The resulting solution
is displayed in (9).
Proof of Theorem 3
We prove this theorem by similar steps as those in the proof of Theorem 2. In Step (a), we show that
(i) p0 is only estimable under a design with at least three distinct group sizes, and (ii) the Ds-optimal
design is unique. Therefore, by Theorem 1, the unique Ds-optimal design has exactly three group sizes,
and one of them is the smallest allowable group size xL. Steps (b) and (c) of this theorem’s proof use
similar arguments as those in the proof of Theorem 2 and have therefore been omitted.
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(i) The result is shown by contradiction. Without loss of generality, suppose there exists a design
ξ = {(xi, wi)}2i=1 such that p0 = eT1 θ is estimable under ξ, where xL ≤ x1 < x2 ≤ xU , w1, w2 ≥ 0,
w1 + w2 = 1, and e1 = (1, 0, 0)T. Therefore, e1 belongs to the range of M(ξ) = Mf (ξ) ·Diagλ(ξ) ·
Mf (ξ)
T, whereMf (ξ) = [f(x1) f(x2)] and Diagλ(ξ) = diag(w1λ(x1), w2λ(x2)). Hence, e1 belongs
to the range of Mf (ξ), or equivalently, the determinant of (f(x1) f(x2) e1) = 0. However,
|f(x1) f(x2) e1| =
∣∣∣∣∣∣∣
x1(p1 + p2 − 1)(1− p0)x1−1 x2(p1 + p2 − 1)(1− p0)x2−1 1
1− (1− p0)x1 1− (1− p0)x2 0
−(1− p0)x1 −(1− p0)x2 0
∣∣∣∣∣∣∣
= (1− p0)x1 − (1− p0)x2 > 0
for arbitrary x1 < x2 and p0 ∈ (0, 1). This contradiction shows that p0 is only estimable under a
design with at least three points.
(ii) Suppose that there are two different Ds-optimal designs, ξ1 and ξ2, with at least 3 points. Let
ξ = 12ξ1 +
1
2ξ2. Therefore, ξ must have at least 4 different support points due to ξ1 6= ξ2 and
Lemma 2. By the concavity of Φs, we have that Φs[M(ξ)] ≥ Φs[M(ξ1)] = Φs[M(ξ2)], and hence
ξ is also Ds-optimal. By the equivalence theorem (see for example, section 2.7 of Fedorov (1972)
or section 10.3 of Atkinson et al. (2007)), we must have
φs(x, ξ) = 1− λ(x)f(x)TM(ξ)−f(x) + λ(x)fs(x)TMs(ξ)−fs(x) ≥ 0 for all x ∈ [xL, xU ],
with equality at each support point of ξ, where fs(x) = (f1(x), f2(x))T and Ms(ξ) is the 2 × 2
submatrix of M(ξ) deleting its first row and first column. Therefore, there exists a small enough
 > 0 such that φs(x, ξ) −  has at least 4 × 2 − 2 = 6 roots. In contrast, by direct calculation,
φs(x, ξ)−  =
∑5
i=0 disiΨi(a) for some di ∈ R with
∑5
i=0 d
2
i > 0, where a = (1− p0)x−xL ∈ [r, 1]
and {siΨi}5i=0 is a Chebyshev system on [r, 1] by (15). Therefore, Theorem 4.1 on page 22 of
Karlin & Studden (1966) shows that φs(x, ξ) −  has at most 5 roots. This contradiction shows
that the Ds-optimal design is unique.
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